LAL CL02: A Multi-Center, Randomized, Placebo-Controlled Study of SBC-102 in Patients with Lysosomal Acid Lipase Deficiency

Project: Research project

Project Details

StatusFinished
Effective start/end date3/6/13 → 9/10/18

Funding

  • Synegeva BioPharma Corporation (LAL CL02)